In this issue:
New tool offers safer alternatives for potentially inappropriate medications
Australian aged care sector reforms
The new rights-based Aged Care Act
New Support at Home program
Changes to funding of residential care
TGA registrations
New inhalers for asthma and COPD
Novel aflibercept biosimilars
AusPAR for donanemab
PBS listings
Upcoming PBAC agenda
PBS subsidy of molnuparavir for Aboriginal people with COVID-19
Dual medicine labelling requirement has ended
FDA approves blood test for Alzheimer's disease
Lecanemab may be safe in specialty clinical setting
Geriatric clinical decision support tool for use in the ED
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)